Financial Ratios

PLETHICO PHARMACEUTICALS LTD.

NSE : NABSE : 532739ISIN CODE : INE491H01018Industry : Pharmaceuticals & DrugsHouse : Private
BSE7.940 (0 %)
PREV CLOSE ( ) 7.94
OPEN PRICE ( ) 8.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 10351
TODAY'S LOW / HIGH ( )7.94 8.30
52 WK LOW / HIGH ( ) 7.948.3
NSE
This Company is not listed in NSE
Select year
ParticularsMar2014Dec2012Dec2011Dec2010Dec2009
Operational & Financial Ratios
   Earnings Per Share (Rs)-2.56-2.32-11.0512.9826.62
   CEPS(Rs)0.490.12-8.6315.1728.44
   DPS(Rs)0.000.000.002.502.50
   Book NAV/Share(Rs)158.11160.67189.36204.82198.06
   Tax Rate(%)-5.28-11.91-37.1530.740.42
Margin Ratios
   Core EBITDA Margin(%)7.43-0.0410.3122.0725.30
   EBIT Margin(%)13.1110.2013.0722.0126.00
   Pre Tax Margin(%)-1.56-1.48-6.6614.1919.23
   PAT Margin (%)-1.64-1.66-9.149.8319.15
   Cash Profit Margin (%)0.310.09-7.1411.4920.46
Performance Ratios
   ROA(%)-0.51-0.47-2.523.316.89
   ROE(%)-1.61-1.32-5.616.4414.18
   ROCE(%)4.483.133.837.799.77
   Asset Turnover(x)0.310.280.280.340.36
   Sales/Fixed Asset(x)2.752.482.192.703.21
   Working Capital/Sales(x)-1.84-2.09-4.511.191.17
Efficiency Ratios
   Fixed Capital/Sales(x)0.360.400.460.370.31
   Receivable days470.33487.24420.34279.24261.52
   Inventory Days13.4117.2316.9613.6712.95
   Payable days20.4719.2825.3628.8233.55
Valuation Parameters
   PER(x)0.000.000.0028.4014.21
   PCE(x)81.492539.24-40.9524.3013.30
   Price/Book(x)0.251.901.871.801.91
   Yield(%)0.000.000.000.680.66
   EV/Net Sales(x)2.144.275.034.123.95
   EV/Core EBITDA(x)14.19105.1416.3517.1314.38
   EV/EBIT(x)16.3041.8337.9718.4215.10
   EV/CE(x)0.671.191.251.351.41
   M Cap / Sales0.262.192.962.842.74
Growth Ratio
   Net Sales Growth(%)11.7816.99-8.24-5.98-0.03
   Core EBITDA Growth(%)315.90-84.5817.46-17.64-17.97
   EBIT Growth(%)44.00-9.99-45.62-19.55-18.08
   PAT Growth(%)-10.6479.03-185.12-51.25-29.75
   EPS Growth(%)-10.6479.03-185.12-51.25-29.75
Financial Stability Ratios
   Total Debt/Equity(x)1.891.851.350.830.87
   Current Ratio(x)0.730.770.888.0412.04
   Quick Ratio(x)0.710.750.867.7411.56
   Interest Cover(x)0.890.870.662.813.84
   Total Debt/Mcap(x)7.480.970.720.460.46

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.